Prediction of tumour response induced by chemotherapy using modelling of CA-125 kinetics in recurrent ovarian cancer patients

被引：0
|
作者：
M Wilbaux
E Hénin
A Oza
O Colomban
E Pujade-Lauraine
G Freyer
M Tod
B You
机构：
[1] EMR 3738,Department of Medical Oncology and Hematology
[2] Ciblage Thérapeutique en Oncologie,undefined
[3] Faculté de Médecine et de Maïeutique Lyon-Sud Charles Mérieux,undefined
[4] Université Claude Bernard Lyon 1,undefined
[5] Princess Margaret Hospital,undefined
[6] University Health Network,undefined
[7] Hôpital Hôtel Dieu,undefined
[8] Place du Parvis Notre-Dame,undefined
[9] Service d’Oncologie Médicale,undefined
[10] Investigational Center for Treatments in Oncology and Hematology of Lyon,undefined
[11] Centre Hospitalier Lyon-Sud,undefined
[12] Hospices Civils de Lyon,undefined
来源：
British Journal of Cancer | 2014年 / 110卷
关键词：
CA-125 kinetics; ovarian epithelial cancer; mathematical modelling; K–PD modelling; tumour size prediction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1517 / 1524
页数：7
相关论文
共 50 条
  • [21] VCAM-1 complements CA-125 in detecting recurrent ovarian cancer
    Jin Song
    Lori J. Sokoll
    Zhen Zhang
    Daniel W. Chan
    Clinical Proteomics, 2023, 20
  • [22] VCAM-1 complements CA-125 in detecting recurrent ovarian cancer
    Song, Jin
    Sokoll, Lori J. J.
    Zhang, Zhen
    Chan, Daniel W. W.
    CLINICAL PROTEOMICS, 2023, 20 (01)
  • [23] MEASUREMENT OF THE OVARIAN CANCER-ASSOCIATED ANTIGEN CA-125 IN MONITORING TUMOR BURDEN AND RESPONSE TO CHEMOTHERAPY
    QUARANTA, M
    COVIELLO, M
    DONADEO, A
    RELLA, C
    LORUSSO, V
    MICELLI, G
    LUCARELLI, C
    TUMORI JOURNAL, 1991, 77 (02): : 167 - 169
  • [24] EFFECT OF NEOADJUVANT CHEMOTHERAPY ON CA-125 SECRETION AND TELOMERASE ACTIVITY IN OVARIAN CANCER
    Atallah, D.
    Antoun, S.
    Moubarak, M.
    El Kassis, N.
    Chahine, G.
    Hilal, G.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1411 - 1411
  • [25] SERIAL CA-125 LEVELS DURING CHEMOTHERAPY FOR METASTATIC OR RECURRENT ENDOMETRIAL CANCER
    FANNING, J
    PIVER, MS
    OBSTETRICS AND GYNECOLOGY, 1991, 77 (02): : 278 - 280
  • [26] Role of Extended Chemotherapy in Advanced Ovarian Cancer Patients with High Posttreatment Serum CA-125 Levels
    Kang, Sokbom
    Kim, Tae-Joong
    Seo, Sang-Soo
    Kim, Byoung-Gie
    Bae, Duk-Soo
    Park, Sang-Yoon
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2011, 72 (01) : 50 - 54
  • [27] Chemotherapy-induced changes of CA 125 in patients with epithelial ovarian cancer
    Sogaard, CH
    Lindegaard, JC
    Havsteen, H
    Nielsen, OS
    Mogensen, O
    GYNECOLOGIC ONCOLOGY, 2005, 97 (02) : 410 - 412
  • [28] The "real-life" variability of CA-125 in ovarian cancer patients
    Tso, Elisa
    Elson, Paul
    VanLente, Fred
    Markman, Maurie
    GYNECOLOGIC ONCOLOGY, 2006, 103 (01) : 141 - 144
  • [29] CA-125 IN THE FOLLOW-UP OF PATIENTS WITH OVARIAN-CANCER
    KOELBL, H
    SCHIEDER, K
    NEUNTEUFEL, W
    BIEGLMAYER, C
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1988, 27 (04): : 335 - 342
  • [30] CA-125 IN THE FOLLOW-UP OF PATIENTS WITH OVARIAN-CANCER
    HALILA, H
    LEHTOVIRTA, P
    STENMAN, UH
    SEPPALA, M
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1988, 67 (01) : 53 - 58
12345